Fund Holdings — TAKEDA PHARMACEUTICAL CO LTD

Total Portfolio Value:
$289.04M
Total Bought:
$1.42M
Total Sold:
$45.35M
Net Transaction:
-$43.94M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
HilleVax, Inc.6,724,0006,724,0000$107.92M$111.82M38.69%+$3.90M
Denali Therapeutics Inc.(DNLI)4,214,5594,214,5590$86.95M$86.48M29.92%-$463.6K
Phathom Pharmaceuticals, Inc.(PHAT)7,459,2863,153,217-4,306,069$77.35M$33.49M11.59%-$43.87M
Ovid Therapeutics Inc.(OVID)7,531,9967,531,9960$24.25M$22.97M7.95%-$1.28M
Shattuck Labs, Inc.(STTK)2,090,8581,501,061-589,797$14.91M$13.42M4.64%-$1.49M
Wave Life Sciences, Inc.SHS(WVE)1,346,8921,346,8920$7.57M$8.31M2.88%+$740.7K
Equillium, Inc.(EQ)1,824,9771,824,9770$1.31M$4.22M1.46%+$2.90M
Turnstone Biologics Corp.895,824895,8240$2.28M$2.35M0.81%+$67.2K
Xilio Therapeutics, Inc.(XLO)1,475,1211,475,1210$811.3K$1.59M0.55%+$781.8K
Day One Biopharmaceuticals, Inc.
COM
085,840+85,840$0$1.42M0.49%+$1.42M
American Well CorporationCL A(AMWL)1,554,6691,554,6690$2.32M$1.26M0.44%-$1.06M
Rani Therapeutics Holdings, Inc.CL A(RANI)338,679338,6790$1.12M$1.05M0.36%-$71.1K
Aerovate Therapeutics, Inc.13,58013,5800$307.3K$401.6K0.14%+$94.2K
Akili, Inc.738,819738,8190$359.8K$214.3K0.07%-$145.5K
Standard BioTools Inc.(LAB)16,51516,5150$36.5K$44.8K0.02%+$8.3K
Page 1 of 1
TAKEDA PHARMACEUTICAL CO LTD — 13F Holdings — Q1 2024 | TickerTrail